The FDA recently showcased the demographic characteristics of study volunteers in clinical trials for drugs that gained approval in 2019. Of the 46,391 participants, nine percent of study volunteers were Black/African American, the same percentage were Asian, and 18 percent were Hispanic. This lack of representation results in inequities in our health care system and Continued
The post Under-representation of minority populations in clinical trials contributory factor in health care inequities; Free virtual event seeks to educate Chicago on the benefits of participation appeared first on Chicago Defender.
